CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This research study is studying several new investigational drug combinations as a possible treatment for follicular lymphoma.The drugs invo...
Phase 1
Saint Louis, Missouri, United States and 5 other locations
The purpose of this study is to evaluate the safety, tolerability, and preliminary efficacy of CC-99282 alone and in combination with anti-lymphoma...
Phase 1, Phase 2
Saint Louis, Missouri, United States and 89 other locations
order to see how well it works in patients with untreated follicular lymphoma. Mosunetuzumab is an antibody that has been engineered to atta...
Phase 2
Saint Louis, Missouri, United States
autologous stem cell transplant for patients with aggressive B cell lymphomas. Mosunetuzumab is an antibody that has been engineered to atta...
Phase 1
Saint Louis, Missouri, United States
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections). Classic...
Phase 2
Chesterfield, Missouri, United States and 61 other locations
in participants with relapsed or refractory (R/R) CD30-expressing lymphomas.GEN3017 will be administered via subcutaneous injections.All par...
Phase 1, Phase 2
Saint Louis, Missouri, United States and 5 other locations
This study will characterize the safety and clinical benefit of valemetostat tosylate in participants with relapsed/refractory peripheral T-cell lymphoma...
Phase 2
Saint Louis, Missouri, United States and 59 other locations
This is a First-in-Human Phase I trial of ATG-101 in Patients with Metastatic/Advanced Solid Tumors and Mature B-cell Non-Hodgkin Lymphomas....
Phase 1
Saint Louis, Missouri, United States and 7 other locations
treatment of advanced classical Hodgkin lymphoma(HL)...
Phase 3
Saint Louis, Missouri, United States and 215 other locations
study is to find out whether the combination of glofitamab and lenalidomide is an effective treatment for relapsed or refractory Mantle Cell Lymphoma...
Phase 1
Saint Louis, Missouri, United States and 9 other locations
Clinical trials
Research sites
Resources
Legal